Exenatide may aggravate moderate diabetic renal impairment: a case report

被引：27

作者：

Johansen, Odd Erik ^{[1
]}

Whitfield, Rolf ^{[1
]}

机构：

[1] Asker & Baerum Hosp, Diabet Out Patient Clin, Dept Med, Rud, Norway

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2008年 / 66卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.2008.03221.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：568 / 569

页数：2

共 6 条

[1] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[2]

Datapharm Communications Ltd, EL MED COMP

[3] Effect of renal impairment on the pharmacokinetics of exenatide [J].

Linnebjerg, Helle ;

Kothare, Prajakti A. ;

Park, Soomin ;

Mace, Kenneth ;

Reddy, Shobha ;

Mitchell, Malcolm ;

Lins, Robert .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (03) :317-327

[4] Level of renal function at the initiation of dialysis in the US end-stage renal disease population [J].

Obrador, GT ;

Arora, P ;

Kausz, AT ;

Ruthazer, R ;

Pereira, BJG ;

Levey, AS .

KIDNEY INTERNATIONAL, 1999, 56 (06) :2227-2235

[5] Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection [J].

Sheffield, Catherine A. ;

Kane, Michael P. ;

Busch, Robert S. .

PHARMACOTHERAPY, 2007, 27 (10) :1449-1455

[6]

Viswanathan Prabhakar, 2007, Endocr Pract, V13, P444

← 1 →